#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hereditary ataxia NTRK gene fusion overexpression Immune thrombocytopenia Tuberous sclerosis complex Neutropenia Thrombocytopenia Cerebellar ataxia Chronic hepatitis B Brain injury Autoimmune demyelinating disease Pleural mesothelioma Rectal cancer Proteus syndrome Blastic plasmacytoid dendritic cell neoplasia Propionic acidaemia More trials…

    Learn about Rare Diseases

    Glomerulonephritis rapidly progressive Haemophilia A with anti factor VIII – Basic Information Lysosomal storage disorder – Life with Disease Andersen-Tawil syndrome – Life with Disease Paroxysmal nocturnal haemoglobinuria – Life with Disease Bronchiolitis obliterans syndrome – Treatment Mast cell activation syndrome – Diagnostics Factor VIII deficiency – Trials in Disease Mitochondrial myopathy – Basic Information Glomerulonephritis membranous – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tradipitant Urapidil ALLERGEN EXTRACTS Vibostolimab Tacrolimus Monohydrate Emapalumab Tigulixostat RUBIDIUM CHLORIDE Tirbanibulin BIIB115 Cl-Ad-Msc-002 Tramadol Gtaexs617 Barzolvolimab Dexamethasone Sodium Phosphate Trifluridine Lavender Oil VAMIFEPORT TRIHYDROCHLORIDE Promethazine Hydrochloride Doxorubicin Hydrochloride More therapies…

    Learn about Your Condition

    Aneurysm ruptured HER2 negative breast cancer Deafness bilateral Erythema multiforme Glaucoma Gaucher's disease type I Acute lymphocytic leukaemia HER2 positive breast cancer Demyelination Angiopathy Hypervolaemia Plasmablastic lymphoma Cerebellar ataxia Melanoma recurrent Sciatica More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study on the Safety and Effectiveness of Dexlansoprazole for Treating Nonerosive GERD in Children Aged 2 to 11 Years

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Gastrooesophageal reflux disease
    Investigated Drugs:
    • Dexlansoprazole
    Poland

  • Study on the Safety and Effectiveness of 166Holmium Radiation Therapy with Atezolizumab and Bevacizumab for Patients with Non-Resectable Liver Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Human Albumin As Macroaggregates
    • Atezolizumab
    • Bevacizumab
    France

  • Study on Esomeprazole Magnesium for Maintaining Healing of Erosive Esophagitis in Children Aged 1 to 11 Years

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Erosive oesophagitis
    Investigated Drugs:
    • Esomeprazole Magnesium
    Belgium Greece Italy Lithuania Portugal Spain

  • Study on Subcutaneous Infliximab for Patients with Ulcerative Colitis, Crohn’s Disease, or Unclassified Inflammatory Bowel Disease

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Inflammatory bowel disease
    • Crohn’s disease
    • Colitis ulcerative
    Investigated Drugs:
    • Infliximab
    Belgium

  • Study Comparing Sacituzumab Govitecan with Standard Treatment for Patients with Metastatic Colorectal Cancer

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Tipiracil
    • Trifluridine
    • Bevacizumab
    Germany

  • Study of resmetirom (MGL-3196) in patients with Non-Alcoholic Steatohepatitis (NASH) to prevent liver damage and disease progression

    Not recruiting

    3 1
    Investigated Drugs:
    • Resmetirom
    Austria Belgium France Germany Hungary Italy +2
Previous Page
1 … 75 76 77 78 79 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!